NCT07053826

Brief Summary

The goal of this study is to determine whether or not the use of a penile traction therapy device known as RestoreX prior to implantation of a penile prosthesis can increase the length of the implant used during surgery. The device used in this study is commercially available and has been used successfully to facilitate penile lengthening in patients with diabetes and after a certain type of prostate surgery. Use of the device has not been shown to have any detrimental effects on sexual or overall health.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Aug 2025Feb 2027

First Submitted

Initial submission to the registry

June 27, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 8, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

August 26, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

September 5, 2025

Status Verified

August 1, 2025

Enrollment Period

11 months

First QC Date

June 27, 2025

Last Update Submit

August 29, 2025

Conditions

Keywords

Erectile DysfunctionInflatable Penile ProsthesisPenile Traction TherapyRestoreXPenile Enlargement

Outcome Measures

Primary Outcomes (4)

  • Penile Length

    Change in stretched penile length measured at time of enrollment and intraoperatively at the time of IPP implantation, measured in cm.

    At screening to approximately three months after enrollment at the time of penile prosthesis implantation

  • Prosthesis size

    Size of inflatable penile prosthesis cylinders placed

    0-4 months after enrollment at the time of penile prosthesis implantation

  • Sexual Satisfaction

    Change in patient-reported satisfaction with their sexual function from enrollment to final postoperative follow up using the validated IIEF-15 (International Index of Erectile function - 15 item) questionnaire, which has a minimum score of 6 and maximum score of 75 with a larger number indicating improved sexual satisfaction. The change seen in participants assigned to the RestoreX device arm will be compared to the change seen in patients assigned to the control arm.

    At enrollment and at three-month postoperative follow up.

  • Incidence of Satisfaction with Penile Length

    A comparison of the incidence of participants reporting satisfaction with their penile length, expressed as a percentage or all participants within each group, based on participant reporting to an investigator during their surgical follow up.

    3-8 months postoperatively

Secondary Outcomes (4)

  • Compliance with Therapy

    0-4 months after enrollment, intervention arm only

  • Incidence of adverse events

    0-16 months

  • Patient Satisfaction with Prosthesis Use

    3-7 months

  • Patient Satisfaction with Prosthesis Use

    3-8 months

Study Arms (2)

Penile Prosthesis Implantation

ACTIVE COMPARATOR

Patients with erectile dysfunction presenting for placement of a three-piece inflatable prosthesis who are randomized to the no intervention arm will proceed directly to implantation of a standard-of-care inflatable penile prosthesis at the next available surgical appointment. They will not use the RestoreX penile traction device. They will complete standardized assessments of sexual function and satisfaction before and after placement.

Procedure: Inflatable Penile Prosthesis Implantation

RestoreX and Penile Prosthesis Implantation

EXPERIMENTAL

Patients with erectile dysfunction presenting for placement of a three-piece inflatable prosthesis who are randomized to the intervention arm will be provided with a RestoreX penile traction device, which they will utilize for three months prior to implantation of a standard-of-care inflatable penile prosthesis. They will complete standardized assessments of sexual function and satisfaction before and after placement, as well as a device use diary.

Device: Penile Traction DeviceProcedure: Inflatable Penile Prosthesis Implantation

Interventions

Patients will be randomized into one of two groups: penile traction therapy 30 min 3x/day x 3 months, or control (no treatment). Preoperative erectile function surveys will be recorded in the EMR per standard of care. Following randomization, patients allocated to the treatment arm will be instructed how to use the device properly. Patients in the treatment arm will record a daily journal of use of the device (Appendix 1). After a minimum of 3 months, patients in the treatment arm will return for their scheduled procedure. Control arm patients will be scheduled directly for an OR date.

Also known as: RestoreX, PTT
RestoreX and Penile Prosthesis Implantation

Implantation of a three-component inflatable penile prosthesis.

Penile Prosthesis ImplantationRestoreX and Penile Prosthesis Implantation

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have a documented diagnosis of erectile dysfunction
  • Can provide informed consent
  • Are willing and able to comply with study procedures and visit schedules
  • Are to be scheduled for a planned standard of care implantation of an inflatable penile prosthesis

You may not qualify if:

  • Prior ischemic priapism
  • Prior implantation of a penile prosthesis
  • Prior use of any penile traction device
  • Any prior penile surgeries other than circumcision
  • Prior pelvic radiation
  • Current or prior androgen deprivation therapy
  • Active genital infection
  • History of neophallus creation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPMC Mercy Hospital, Urology

Pittsburgh, Pennsylvania, 15219, United States

RECRUITING

Related Publications (5)

  • Ziegelmann M, Savage J, Toussi A, Alom M, Yang D, Kohler T, Trost L. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial. J Urol. 2019 Sep;202(3):599-610. doi: 10.1097/JU.0000000000000245. Epub 2019 Aug 8.

    PMID: 30916626BACKGROUND
  • Zganjar A, Toussi A, Ziegelmann M, Frank I, Boorjian SA, Tollefson M, Kohler T, Trost L. Efficacy of RestoreX after prostatectomy: open-label phase of a randomized controlled trial. BJU Int. 2023 Aug;132(2):217-226. doi: 10.1111/bju.16033. Epub 2023 May 9.

    PMID: 37088866BACKGROUND
  • Toussi A, Ziegelmann M, Yang D, Manka M, Frank I, Boorjian SA, Tollefson M, Kohler T, Trost L. Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled Trial. J Urol. 2021 Aug;206(2):416-426. doi: 10.1097/JU.0000000000001792. Epub 2021 Jun 1.

    PMID: 34060339BACKGROUND
  • Trost LW, Munarriz R, Wang R, Morey A, Levine L. External Mechanical Devices and Vascular Surgery for Erectile Dysfunction. J Sex Med. 2016 Nov;13(11):1579-1617. doi: 10.1016/j.jsxm.2016.09.008.

    PMID: 27770853BACKGROUND
  • Levine LA, Rybak J. Traction therapy for men with shortened penis prior to penile prosthesis implantation: a pilot study. J Sex Med. 2011 Jul;8(7):2112-7. doi: 10.1111/j.1743-6109.2011.02285.x. Epub 2011 Apr 14.

    PMID: 21492409BACKGROUND

MeSH Terms

Conditions

Erectile Dysfunction

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Officials

  • J. Peter Rubin, MD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Roger D Klein, MD, PhD

CONTACT

Michelle Lucas, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a double-armed, controlled, open-label randomized trial assessing the above outcomes in the presence or absence of preoperative penile traction device (RestoreX) use.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Endowed Chair of Plastic Surgery

Study Record Dates

First Submitted

June 27, 2025

First Posted

July 8, 2025

Study Start

August 26, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

September 5, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

To protect the privacy of the patients involved in the study, we do not plan to share IDP.

Locations